General Discussion, page-1631

First 1631 Last

Share
Profile

Follow
Maltisani

869 Posts.

163

17/01/23

18:34

Post #: 65739033
Share

Originally posted by qwert0: ↑

I certainly think that ESS could mange the DSO option themselves. They did it with the cesium and we now employ a marketing director with recent experience selling lithium DSO. It's definitely an option that is still on the table.

People seem to be making the assumption that we have to sell to someone. That isn't the case at all. Obviously we won't be accepting the 50c bid. Anyone willing to sell at that price would have already sold. If the bid isn't raised or countered then it's back to plan A.

Just because the board approved the bid doesn't mean they actually want to sell. They're satisfying their legal responsibility to act in the best interests of shareholders and present us with the opportunity to sell at a price 50% above what it was 2 weeks ago.

We are the ones who decide how this plays out.

Expand

You make a good point in regards to anyone willing to accept 50c, probably having already sold.

However, I doubt this particular deal will get as far as a SH vote.

Clearly if we are trading above 50c, the current offer is hardly in SH best interests.

Then there is the FIRB, which I'd imagine will be a significant hurdle in the current geopolitical climate.

ESS Price at posting: 50.0¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 1631 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

General Discussion, page-1631

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News